Since both HMGB1 and HMGN1 are known to trigger DC maturation (19–21), these results substantiate the notion that DAMPs/alarmins released by tumor cells in response to LTX-315 treatment contribute to DC maturation. This evidence concerns the gene HMGN1 and neoplasm.